PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
作者信息
BLOEDOW C E
出版信息
Cancer Chemother Rep. 1964 Aug;40:39-41.
PMID:14206914
Abstract
摘要
相似文献
1
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
Cancer Chemother Rep. 1964 Aug;40:39-41.
2
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
Cancer Chemother Rep. 1964 Aug;40:47-8.
3
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
Cancer Chemother Rep. 1964 Aug;40:51-2.
4
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG.
Cancer Chemother Rep. 1964 Aug;40:45-6.
5
PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).
Cancer Chemother Rep. 1964 Aug;40:37-8.
6
HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY.
Cancer Chemother Rep. 1964 Aug;40:33-6.
7
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
Cancer Chemother Rep. 1964 Aug;40:53-5.
8
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
Cancer Chemother Rep. 1964 Aug;40:43.
9
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA.
Cancer Chemother Rep. 1964 Aug;40:49-50.
10
ERYTHEMA IN AREAS OF PREVIOUS IRRADIATION IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).
Cancer Chemother Rep. 1964 Aug;40:31-2.
引用本文的文献
1
Hydroxyurea therapy for sickle cell anemia.
Expert Opin Drug Saf. 2015;14(11):1749-58. doi: 10.1517/14740338.2015.1088827. Epub 2015 Sep 14.
2
Hydroxyurea inhibition of DNA synthesis in ascites tumor.
Proc Natl Acad Sci U S A. 1965 May;53(5):1033-5. doi: 10.1073/pnas.53.5.1033.
3
[Studies on the teratogenic effect of hydroxyurea during the early and embryonic development of mice].
Arch Toxikol. 1969;25(2):150-68.
Zotero 插件